Endothelium as a Predictor of Adverse Outcomes

By  

Clinical Cardiology, Vol. 33, Iss. 12, 2010-12 ,pp. : 730-732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Will Sodium Intake Reduction Improve Cardiovascular Outcomes in the General Population? A Critical Review of Current Evidence

By  

Current Hypertension Reviews, Vol. 11, Iss. 1, 2015-04 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

The causes of misdiagnosis and adverse outcomes in PGD

By Wilton L.   Thornhill A.   Traeger-Synodinos J.   Sermon K.D.   Harper J.C.  

Human Reproduction, Vol. 24, Iss. 5, 2009-05 ,pp. : 1221-1228

Oxford University Press

Access to resources Recommend Favorite

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Johnson J.   Simpson S.   Eurich D.   Majumdar S.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2805-2806

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Tayek J.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2807-2808

Springer Publishing Company

Access to resources Recommend Favorite